SyncroPhi Systems
Patient Monitor | Wireless Vital Signs| EWS.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €1.0m | Seed | |
| Total Funding | 000k | ||
| EUR | 2015 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| % profit margin | (179 %) |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Syncrophi Systems Ltd was established in 2007. In addition to Founder investment the company is financially backed by venture funds, private investors and the Irish Government (via Enterprise Ireland). It is dedicated to developing informatics systems for deployment in healthcare settings. The company has maintained a certified medical-grade Quality Management System (ISO13485) since 2008 and all of its product development work complies with the Medical Device Software Standard (EN62304). Its KEWS300 product is CE-marked in compliance with the EU’s Medical Device Directive and is also FDA-cleared. The company is based in Galway, in the heart of Ireland’s medtech hub.
Syncrophi is also a core member of the international Diginewb consortium under the auspices of the flagship Horizon2020 program. This is a 4-year, fully-funded project to research and develop an improved monitoring system for neonates and pre-term infants in a NICU environment. http://www.digi-newb.eu/